Connect with us

Technology

MySize present year over year growth, 2025 targets $15M Revenue, Anticipates Strong 2024 Finish close to 100% Growth from 2022

Published

on

Strong Revenue Growth, Strategic Market Expansion, M&A strategy and Cutting-Edge Technology Set the Stage for Continued Success

AIRPORT CITY, Israel, Dec. 27, 2024 /PRNewswire/ — MySize, Inc. (NASDAQ: MYSZ)

(“MySize” or the “Company”), a global leader in AI-driven sizing solutions and omnichannel e-commerce platforms, today shared its annual shareholder update. The update highlights robust revenue growth, strategic geographic expansion, transformative technological advancements, and plans to explore M&A opportunities within the Company’s core industries.

Delivering on Growth and Performance

MySize anticipates closing 2024 with $8.5 million in revenue, reflecting a 23% year-over-year growth. MySize believes that this momentum, fueled by advancements in technology and market expansion of Orgad, potentially positions the Company to achieve a projected $15 million in revenue by 2025 based on current market conditions. Moreover, the Company believes that it will be able to achieve further significant operational cost savings that will enhance a flexibility in cash flow management and provide the foundation for continued strategic investment and growth.

“Our preliminary financial results highlight Orgad’s pivotal role in driving our revenue growth. By optimizing operational efficiency and capitalizing on strategic market expansions, Orgad demonstrates its capacity to deliver strong performance while providing the flexibility needed to pursue ambitious targets,” said Ronen Luzon, Founder and CEO of MySize. “2024 has proven that our strategy is not just ambitious, but highly effective, and we believe that it lays the groundwork for sustainable growth.”

Expanding Geographic Reach

MySize’s e-commerce platform, Orgad, is undergoing a strategic shift from focusing primarily on North America to expanding operations across Europe.

This move follows the receipt of certification to become a supplier for a major European retailer. This milestone represents significant growth potential and has the potential to unlock new opportunities in one of the world’s largest retail markets. The Company believes this strategic expansion demonstrates Orgad’s ability to adapt and capitalize on emerging opportunities.

“We believe that Europe represents a significant opportunity for Orgad as we tap into new markets and strengthen relationships with global retail leaders,” Luzon added. “The certification as a supplier to a leading European retailer underscores our commitment to delivering excellence.”

Pioneering Innovation with Naiz Fit

The Company’s AI-driven sizing solution, Naiz Fit, continues to set industry benchmarks:

✅ Delivered over 42 million personalized size recommendations across 18+ countries, enabling customers to find their perfect fit.✅ Supported 1.5 million virtual try-ons, ensuring precision and enhancing consumer confidence.✅ Increased conversion rates by 5.7x, reducing friction in the purchasing journey.✅ Achieved a 14% reduction in return rates, driving cost savings and operational efficiency for retail partners.✅ Boosted average order value (AOV) by 27%, reinforcing the financial value of MySize’s solutions.✅ Improved consumer engagement by 15%, creating stronger connections between brands and their customers.

Interestingly, trousers emerged as the most frequently returned item, providing valuable insights that MySize leverages to refine its technology further and support its partners.

“Naiz Fit continues to solidify our position as a technological leader in the fashion and retail space,” Luzon remarked. “These results are a testament to the impact and effectiveness of our solutions.”

Looking Ahead

“As we reflect on 2024, I am proud of how far MySize has come,” Luzon concluded. Building on this momentum, MySize is gearing up for a strong presence at two key industry events in January 2025: CES in Las Vegas and NRF in New York. These events present unique opportunities to showcase our cutting-edge technologies and connect with global leaders in the retail and e-commerce industries.

Additionally, MySize is actively exploring mergers and acquisitions (M&A) to enhance growth opportunities and scale operations. By targeting companies aligned with its expertise in AI-driven sizing solutions, e-commerce platforms, and operational technologies, MySize aims to:

Expand Product Offerings: Enhance the range of technologies and solutions, providing clients with more robust and innovative tools.Accelerate Market Reach: Broaden geographic penetration, especially in untapped regions, and strengthen relationships in existing markets.Optimize Operational Synergies: Drive cost efficiencies and maximize profitability through integration with complementary businesses.

“Our approach to M&A is grounded in strategic alignment and long-term value creation,” Luzon emphasized. “By leveraging these opportunities, we aim to scale our business and unlock innovative pathways that support sustainable growth and deliver meaningful results for our shareholders.”

“We believe that our strategic expansion, cutting-edge technology, and commitment to innovation position us for an exciting future. Together, with our partners and investors, we aim to shape the future of fashion and e-commerce.”

About MySize, Inc.

MySize, Inc. (NASDAQ: MYSZ) is a global leader in omnichannel e-commerce platforms and AI-driven sizing solutions, including MySizeID and Naiz Fit. The Company’s solutions are designed to drive revenue growth, reduce operational costs, and enhance customer experiences for business clients worldwide.

We routinely post information that may be important to investors in the Investor Relations section of our website. Follow us on Facebook, LinkedIn, Instagram, and X (formerly known as Twitter).

For more information, visit www.mysizeid.com.

Estimated Preliminary Results for the Year Ending December 31, 2024 (Unaudited)

Set forth above are certain estimated preliminary financial results and other business metrics for the year ended December 31, 2024. These estimates are based on the information available to us at this time. Our actual results may differ materially from the estimated preliminary results presented due to the completion of our financial closing and accounting procedures, including final adjustments, the completion of the preparation and audit of the Company’s financial statements and the subsequent occurrence or identification of events prior to the filing of the audited consolidated financial statements for the fiscal year ending December 31, 2024, in the Company’s Annual Report on Form 10-K. The estimated preliminary financial results and other business metrics have not been audited or reviewed by our independent registered public accounting firm. These estimates should not be viewed as a substitute for our full interim or annual financial statements. Accordingly, you should not place undue reliance on this preliminary data. In addition, any such statements regarding the Company’s financial performance are not necessarily indicative of the Company’s financial performance that may be expected to occur for the fiscal year ending December 31, 2024, or for any future fiscal period.

Forward-looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to its strategic and business plans, technology, relationships, objectives, expectations for its business, growth, expected revenue guidance and potential merger and acquisition opportunities. These statements are identified by the use of the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “may,” “continue,” “predict,” “potential,” “project” and similar expressions that are intended to identify forward-looking statements. All forward-looking statements speak only as of the date of this press release. You should not place undue reliance on these forward-looking statements. Although we believe that our plans, objectives, expectations and intentions reflected in or suggested by the forward-looking statements are reasonable, we can give no assurance that these plans, objectives, expectations or intentions will be achieved. Forward-looking statements involve significant risks and uncertainties (some of which are beyond our control) and assumptions that could cause actual results to differ materially from historical experience and present expectations or projections. Actual results may differ materially from those in the forward-looking statements and the trading price for our common stock may fluctuate significantly. Forward-looking statements also are affected by the risk factors described in the Company’s filings with the U.S. Securities and Exchange Commission. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Investor Contacts

Or Kles, CFO
Email: ir@mysizeid.com

Logo – https://mma.prnewswire.com/media/689689/3320229/MySize_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/mysize-present-year-over-year-growth–2025-targets-15m-revenue–anticipates-strong-2024-finish-close-to-100-growth-from-2022-302339582.html

SOURCE My Size Inc.

Continue Reading

Technology

Sophia Space and MIT Lincoln Laboratory Announce Research Collaboration on Space-Based Weather Modeling

Published

on

By

CRADA and related SpaceWERX Phase I research will explore space-based computing approaches for weather-modeling applications

PASADENA, Calif., Oct. 20, 2026 /PRNewswire/ — Sophia Space today announced a new Cooperative Research and Development Agreement (CRADA) with MIT Lincoln Laboratory to investigate how space-based computing approaches could support high-resolution weather-modeling research for remote operating environments.

The collaboration combines MIT Lincoln Laboratory’s weather-modeling research expertise with Sophia Space’s edge-compute concepts. The effort will explore whether distributed computing can support more timely environmental information for planning and decision-support applications.

Under the agreement, MIT Lincoln Laboratory will contribute weather-modeling research expertise, including the identification of modeling configurations, parameters, and data sources for evaluation. The team will develop representative test data and assess weather-model performace against defined research metrics using frameworks compatible with Sophia Space’s initial hardware configurations.

Sophia Space will provide the AI-inference compute environment for evaluating representative weather-model workloads, including terrestrial and potential space-based computing configurations. The organizations will explore high-level system and service architectures that may inform future research into space-based computing applications.

Sophia Space and MIT Lincoln Laboratory are also pursuing related work under Department of the Air Force STTR Topic SF25D-T1201 through the SpaceWERX Futures Series: Adaptive and Intelligent Space Challenge. The related effort examines technologies relevant to autonomous, resilient, and networked space-system operations.

“This partnership reflects our conviction that space-based computing infrastructure should be developed through rigorous collaboration between commercial innovators and world-class research institutions,” said Rob DeMillo, Co-founder and CEO of Sophia Space. “MIT Lincoln Laboratory brings unmatched weather sensing, forecasting and decision-support research expertise, and together we will explore the potential application of space-based computing to weather-modeling research.”

The collaboration aligns with Sophia Space’s research interests in edge-compute architectures, distributed processing, and sensor fusion integration for environments.

“Timely weather information is critical for operations in remote and contested environments,” said Dr. Timothy Bonin, Assistant Group Leader of the Air Traffic Control & Weather Systems Group at MIT Lincoln Laboratory. “This collaboration allows us to explore how space-based computing can help process satellite observations and other environmental data closer to the point of collection, while assessing potential impacts on communications demands and information-delivery timelines.”

About Sophia Space Inc.
Sophia Space is building the future of orbital computing and in-space data centers. Its modular TILE (Thermal-Integrated LEO Edge) technology enables passive computing alongside in-situ data processing, AI acceleration, and edge computing for satellites, defense systems, and commercial space stations—dramatically reducing latency and delivering actionable insights where and when they are needed. Learn more at www.sophia.space.

About MIT Lincoln Laboratory
MIT Lincoln Laboratory is a federally funded research and development (R&D) center chartered to apply advanced technology to problems of national security. Since 1951, the Laboratory has developed technology that has transformed the activities of the defense, scientific, and industry communities. Its mission focuses on long-term technology development as well as rapid system prototyping and demonstration. Through several mechanisms, it facilitates partnerships with companies to advance R&D and increase U.S. technical competitiveness. Learn more at www.ll.mit.edu.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-space-and-mit-lincoln-laboratory-announce-research-collaboration-on-space-based-weather-modeling-302913439.html

SOURCE Sophia Space

Continue Reading

Technology

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

Published

on

By

Collaboration to connect AstraZeneca’s scientific and therapeutic expertise with Oracle’s real-world data, cloud, AI, and clinical capabilities to accelerate clinical research and bring evidence-driven insights into care workflows to help improve patient care

AUSTIN, Texas and ABU DHABI, UAE, Oct. 20, 2026 /PRNewswire/ — Oracle today announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible patients for clinical trials, accelerate evidence generation, and bring relevant research insights into everyday care. The collaboration is expected to combine AstraZeneca’s scientific and therapeutic expertise with Oracle’s health data, cloud, AI, analytics, and clinical workflow capabilities.

Through a non-binding agreement, the companies plan to explore selected use cases that could improve clinical-trial efficiency and success by leveraging modern applications and AI to help care teams identify eligible patients earlier and easier, resulting in greater access to clinical trials for patients in need and helping to overcome one of the largest obstacles in clinical trials – patient recruitment. Initial disease areas to be explored could include oncology; cardiovascular, renal and metabolic diseases; respiratory and immunology; and rare diseases.

Pascal Soriot, Chief Executive Officer, AstraZeneca said: “This unique collaboration brings leaders in healthcare and AI together at a global scale to accelerate the journey from the discovery of medicine to patient care. Combining AstraZeneca’s world class science with Oracle’s deep data and technology expertise, we can help clinicians identify patients sooner, optimize clinical trials, and generate evidence continuously across the lifecycle of a medicine.”

“Some of the most important opportunities for AI are in healthcare, where better use of data can help turn scientific innovation into better outcomes for patients,” noted Mike Sicilia, chief executive officer, Oracle. “By bringing AstraZeneca’s scientific expertise together with Oracle’s data, cloud, AI, and healthcare capabilities, we have an opportunity to help accelerate research, connect more patients to clinical trials, and ultimately bring relevant insights into care faster.”

Connecting Research and Care

Anne-Claire Gerbaldi, Chief Digital, Data and AI Officer, AstraZeneca, added: “Too many patients are diagnosed late or face a long journey to get the care they need. To build the next decade of medicine, we aim to harness AI to connect learnings across science, clinical trials, and everyday care, generating insights that continuously strengthen research, accelerate innovation, and enhance patient outcomes. Bringing together the unique capabilities of Oracle and AstraZeneca, we believe we can support smarter clinical trials, strengthen safety monitoring, and help ensure patients are diagnosed sooner and receive the right care.”

Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences, said: “Healthcare progress depends on shortening the distance between scientific insight and the decisions clinicians make every day. AstraZeneca brings deep scientific and therapeutic expertise, and Oracle will deliver the secure data, cloud, AI, and clinical workflow capabilities. This collaboration has the potential to help health systems identify eligible patients sooner, broaden access to clinical trials, and generate evidence that supports the next decision, all under the governance of the health systems delivering care.”

AstraZeneca and Oracle intend to explore a continuous learning model in which insights from clinical research and routine care help inform future study design, safety monitoring, and patient care. The companies plan to establish shared governance, reusable technical components, and agreed outcome measures to assess results and determine whether successful approaches could extend across disease areas and geographies.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company – ushering in the new era of cloud computing.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-and-astrazeneca-partner-to-advance-ai-enabled-healthcare-innovation-302913441.html

SOURCE Oracle

Continue Reading

Technology

Loyyal Unveils Perxi AI Business Suite to Help SMEs Run Their Business on WhatsApp

Published

on

By

Branded AI assistant brings everyday business activities into messaging channels, reducing the need for separate software and specialist teams

DUBAI, UAE, Oct. 20, 2026 /PRNewswire/ — Loyyal today unveiled the Perxi AI Business Suite, enabling small and medium enterprises (SMEs) to manage everyday business activities through WhatsApp. Building on its introduction as a loyalty assistant, Perxi brings commerce, customer engagement and business management into one conversational interface, with capabilities including ordering, customer service and loyalty.

The suite helps SMEs and direct-to-consumer brands manage these activities without purchasing separate ordering systems, customer relationship management software or support tools. Its conversational approach reduces the need to hire specialists or train employees to operate multiple systems.

“Small business owners should be able to focus on growth without assembling a collection of software tools,” said Ashish Kumar Singh, Founder and CEO of Loyyal.

“Perxi brings everyday business capabilities into WhatsApp under each business’s own brand. We want to make these tools affordable and accessible while helping businesses retain greater control over their customer relationships, data and decisions.”

Perxi provides the underlying technology, while each business launches its assistant under its own brand name. Customers engage directly with the business they recognise, rather than entering a separate Perxi marketplace.

Customers can place orders, ask questions, receive assistance and access rewards within a familiar conversation. There is no additional branded application to install or separate login to remember. This approach is designed to appeal to younger consumers accustomed to discovering and interacting with brands through mobile messaging.

Beyond WhatsApp, Perxi can be deployed across messaging channels suited to each business and market, including Instagram, WeChat and KakaoTalk.
Multilingual capabilities enable businesses to serve customers in their preferred languages, supporting brands operating beyond English and those engaging diverse communities.

As conversational commerce and AI assistants become more prominent, SMEs face growing expectations for convenient, responsive interactions. Bringing business services into messaging channels offers a way to meet those expectations while building direct customer relationships.

Marketplaces and aggregators offer a fast route to market, but access to customer information and engagement opportunities varies. Perxi helps businesses establish a direct channel and gain insights from their own customer conversations and transactions.

These insights can inform service improvements, personalised engagement and retention, while reducing dependence on intermediaries for customer access.

Pricing is designed to remain simple and affordable. Loyyal plans further services under the same umbrella.

Perxi will return to exhibit at Dubai AI Festival on October 26–27, 2026, at Dubai World Trade Centre.

About Loyyal

Loyyal is a US-born, UAE-based enterprise technology company helping businesses turn loyalty and customer engagement into growth and revenue. Combining patented blockchain technology with AI, its modular portfolio spans loyalty management, rewards, points exchange, offers, gift cards, gamification and conversational business assistants.

Media Contact

Marketingdepartment@loyyal.com

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/loyyal-unveils-perxi-ai-business-suite-to-help-smes-run-their-business-on-whatsapp-302913064.html

Continue Reading

Trending